272 results on '"Xia, Mingfeng"'
Search Results
2. Polydopamine-modified cellulose nanofiber composite hydrogel with strong toughness and high adhesion for human motion detection and wireless sensing
3. DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER
4. Presence of sarcopenia identifies a special group of lean NAFLD in middle-aged and older people
5. The early effects of sleeve gastrectomy on postprandial chylomicron triglycerides during the progression of type 2 diabetes
6. Jatrorrhizine inhibits Piezo1 activation and reduces vascular inflammation in endothelial cells
7. Longitudinal analysis of epigenome-wide DNA methylation reveals novel loci associated with BMI change in East Asians
8. Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease
9. The causal associations of circulating amino acids with blood pressure: a Mendelian randomization study
10. Longitudinal association of peripheral blood DNA methylation with liver fat content: distinguishing between predictors and biomarkers.
11. Association between fast eating speed and metabolic dysfunction-associated steatotic liver disease: a multicenter cross-sectional study and meta-analysis.
12. Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
13. Association of vitamin D deficiency and subclinical diabetic peripheral neuropathy in type 2 diabetes patients
14. Characteristics of changes in plasma proteome profiling after sleeve gastrectomy
15. DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing
16. Acute Effects of Sleeve Gastrectomy on Glucose Variability, Glucose Metabolism, and Ghrelin Response
17. Impact of Type 2 Diabetes on Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
18. Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients
19. Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
20. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
21. Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
22. Highly efficient flame-retardant and low-smoke-toxicity poly(vinyl alcohol)/alginate/ montmorillonite composite aerogels by two-step crosslinking strategy
23. Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open‐label, controlled trial.
24. DNA methylation age acceleration contributes to the development and prediction of non-alcoholic fatty liver disease
25. Dynamic changes in the distribution of facial and abdominal adipose tissue correlated with surgical treatment in acromegaly
26. DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population
27. Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2
28. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c
29. Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans
30. Highly Efficient Flame-Retardant and Enhanced PVA-Based Composite Aerogels through Interpenetrating Cross-Linking Networks
31. Updates of precision medicine in type 2 diabetes
32. Presence of sarcopenia identifies a special group of lean NAFLD in middle-aged and older people
33. Twelve Loci Associated With Bone Density in Middle-aged and Elderly Chinese: The Shanghai Changfeng Study
34. Piezo1 in vascular remodeling of atherosclerosis and pulmonary arterial hypertension: A potential therapeutic target
35. A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease
36. LC–MS-based lipidomic analysis of liver tissue sample from spontaneously hypertensive rats treated with extract hawthorn fruits
37. Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21
38. Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression
39. Nanocellulose-Based Composite Materials Used in Drug Delivery Systems
40. Myeloid Piezo1 Deletion Protects Renal Fibrosis by Restraining Macrophage Infiltration and Activation
41. Editorial: opposite effects of genetic polymorphisms known to induce NAFLD on hepatic and cardiovascular outcomes in Chinese population—authors' reply
42. Inhibition of chemically and mechanically activated Piezo1 channels as a mechanism for ameliorating atherosclerosis with salvianolic acid B
43. Cover Image
44. Additional file 2 of The causal associations of circulating amino acids with blood pressure: a Mendelian randomization study
45. Additional file 3 of The causal associations of circulating amino acids with blood pressure: a Mendelian randomization study
46. NAFLD‐related gene polymorphisms and all‐cause and cause‐specific mortality in an Asian population: the Shanghai Changfeng Study
47. Update on genetics and epigenetics in metabolic associated fatty liver disease
48. Biomarker Discovery in Atherosclerotic Diseases Using Quantitative Nuclear Magnetic Resonance Metabolomics
49. Type 2 Diabetes Is Causally Associated With Reduced Serum Osteocalcin: A Genomewide Association and Mendelian Randomization Study
50. Liver fat content is independently associated with microalbuminuria in a normotensive, euglycaemic Chinese population: a community-based, cross-sectional study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.